Literature DB >> 19384563

The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex.

T Rubino1, N Realini, D Braida, T Alberio, V Capurro, D Viganò, C Guidali, M Sala, M Fasano, D Parolaro.   

Abstract

We recently demonstrated that Delta(9)-tetrahydrocannabinol (THC) chronic administration in female adolescent rats induces alterations in the emotional circuit ending in depressive-like behavior in adulthood. Since cognitive dysfunction is a major component of depression, we assessed in these animals at adulthood different forms of memory. Adolescent female rats were treated with THC or its vehicle from 35 to 45 post-natal days (PND) and left undisturbed until their adulthood (75 PND) when aversive and spatial memory was assessed using the passive avoidance and radial maze tasks. No alteration was found in aversive memory, but in the radial maze THC pre-treated animals exhibited a worse performance than vehicles, suggesting a deficit in spatial working memory. To correlate memory impairment to altered neuroplasticity, level of marker proteins was investigated in the hippocampus and prefrontal cortex, the most relevant areas for learning and memory. A significant decrease in synaptophysin and PSD95 proteins was found in the prefrontal cortex of THC pre-treated rats, with no alterations in the hippocampus. Finally, proteomic analysis of the synapses in the prefrontal cortex revealed the presence of less active synapses characterized by reduced ability in maintaining normal synaptic efficiency. This picture demonstrates the presence of cognitive impairment in THC-induced depressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384563     DOI: 10.1007/s12640-009-9031-3

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  69 in total

1.  Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease.

Authors:  Debra Boyd-Kimball; Alessandra Castegna; Rukhsana Sultana; H Fai Poon; Robin Petroze; Bert C Lynn; Jon B Klein; D Allan Butterfield
Journal:  Brain Res       Date:  2005-04-15       Impact factor: 3.252

2.  Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit.

Authors:  Steven Theroux; Mandy Pereira; Kimberly S Casten; Rebecca D Burwell; Kam C Yeung; John M Sedivy; Jan Klysik
Journal:  Brain Res Bull       Date:  2006-12-11       Impact factor: 4.077

Review 3.  Structural changes accompanying memory storage.

Authors:  C H Bailey; E R Kandel
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

4.  A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis.

Authors:  P Sinha; J Poland; M Schnölzer; T Rabilloud
Journal:  Proteomics       Date:  2001-07       Impact factor: 3.984

5.  Stimulation-evoked increases in cytosolic [Ca(2+)] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent.

Authors:  G David; E F Barrett
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

6.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

7.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

9.  Origins of spatial working memory deficits in schizophrenia: an event-related FMRI and near-infrared spectroscopy study.

Authors:  Junghee Lee; Bradley S Folley; John Gore; Sohee Park
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

10.  Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation.

Authors:  W B Huttner; W Schiebler; P Greengard; P De Camilli
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

View more
  41 in total

Review 1.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity.

Authors:  Jonathan W Lovelace; Alex Corches; Philip A Vieira; Alex S Hiroto; Ken Mackie; Edward Korzus
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 4.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

Authors:  Matthew N Hill
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 6.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

Review 7.  Consequences of adolescent use of alcohol and other drugs: Studies using rodent models.

Authors:  Linda Patia Spear
Journal:  Neurosci Biobehav Rev       Date:  2016-07-30       Impact factor: 8.989

Review 8.  Endocannabinoid system: potential novel targets for treatment of schizophrenia.

Authors:  Atsushi Saito; Michael D L Ballinger; Mikhail V Pletnikov; Dean F Wong; Atsushi Kamiya
Journal:  Neurobiol Dis       Date:  2012-12-07       Impact factor: 5.996

9.  Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats.

Authors:  Ana Belen Lopez-Rodriguez; Alvaro Llorente-Berzal; Luis M Garcia-Segura; Maria-Paz Viveros
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 10.  Cannabinoid mitigation of neuronal morphological change important to development and learning: insight from a zebra finch model of psychopharmacology.

Authors:  Ken Soderstrom; Marcoita T Gilbert
Journal:  Life Sci       Date:  2012-08-01       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.